VPC
ZURA icon

Vestal Point Capital’s Zura Bio ZURA Stock Holding History

Vestal Point Capital’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.93M Buy
1,173,956
+662,956
+130% +$3.16M 0.16% 59
2026
Q1 		$3.04M Buy
+511,000
New +$3.09M 0.09% 80

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vestal Point Capital's ZURA Position: Q2 2026 in Review

Vestal Point Capital increased its Zura Bio (ZURA) stake by 130% in Q2 2026, buying an estimated $3.16M and bringing the position to 1,173,956 shares worth $6.93M. The position accounts for 0.16% of the portfolio, ranked #59.

Vestal Point Capital first reported a position in ZURA in Q1 2026 and has held it in 2 quarters since. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Vestal Point Capital held 1,173,956 shares of Zura Bio worth $6.93M as of Q2 2026.
  • Vestal Point Capital bought 662,956 Zura Bio shares in Q2 2026, an estimated $3.16M.
  • Zura Bio made up 0.16% of Vestal Point Capital's portfolio in Q2 2026, its #59 holding.
  • Vestal Point Capital first reported a position in Zura Bio in Q1 2026 and has held it in 2 quarters since.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Vestal Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.